Stem cell-based ischemic stroke therapy: Novel modifications and clinical challenges

Sun, Yuankai; Jiang, Xinchi; Gao, Jianqing

doi:10.1016/j.ajps.2023.100867

Cited by 1 publication

(1 citation statement)

References 168 publications

(230 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Stem cell studies in treating ISs are extensive, with a predominant focus on the transplantation of stem cells or the administration of stem cell-derived vesicles and trophic cytokines [248][249][250][251][252][253]. At present, fewer studies have been conducted on stem cell membrane-coated nanoparticles for IS therapy [254]. We notice that there was a study using stem cell membrane-coated nanoparticles as a delivery platform, which leveraged the SDF-1/CXCR4 pathway to enhance targeted drug delivery in ISs [255].…”

Section: Other Cell Membrane-coated Nanoparticlesmentioning

confidence: 99%

Advanced Nano-Drug Delivery Systems in the Treatment of Ischemic Stroke

Zhang,

Chen,

Chen

2024

Molecules

View full text Add to dashboard Cite

In recent years, the frequency of strokes has been on the rise year by year and has become the second leading cause of death around the world, which is characterized by a high mortality rate, high recurrence rate, and high disability rate. Ischemic strokes account for a large percentage of strokes. A reperfusion injury in ischemic strokes is a complex cascade of oxidative stress, neuroinflammation, immune infiltration, and mitochondrial damage. Conventional treatments are ineffective, and the presence of the blood–brain barrier (BBB) leads to inefficient drug delivery utilization, so researchers are turning their attention to nano-drug delivery systems. Functionalized nano-drug delivery systems have been widely studied and applied to the study of cerebral ischemic diseases due to their favorable biocompatibility, high efficiency, strong specificity, and specific targeting ability. In this paper, we briefly describe the pathological process of reperfusion injuries in strokes and focus on the therapeutic research progress of nano-drug delivery systems in ischemic strokes, aiming to provide certain references to understand the progress of research on nano-drug delivery systems (NDDSs).

show abstract